Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:19
09/25/20
09/25
16:19
09/25/20
16:19
COST

Costco

$342.25 /

-4.75 (-1.37%)

, WIMHY

William Hill

$0.00 /

+ (+0.00%)

, CZR

Caesars

$57.19 /

+4.4 (+8.33%)

, APO

Apollo Global

$44.72 /

+1.865 (+4.35%)

, NVAX

Novavax

$113.51 /

+11.03 (+10.76%)

, AZN

AstraZeneca

$55.53 /

+1.37 (+2.53%)

, SNY

Sanofi

$50.81 /

+0.04 (+0.08%)

, AAPL

Apple

$112.22 /

+4.02 (+3.72%)

, GOOG

Alphabet

$1,444.74 /

+18.02 (+1.26%)

, GOOGL

Alphabet Class A

$1,440.67 /

+19.2 (+1.35%)

, ORCL

Oracle

$59.80 /

+0.49 (+0.83%)

, WMT

Walmart

$137.25 /

+0.54 (+0.39%)

, BA

Boeing

$156.07 /

+10.08 (+6.90%)

, CLNY

Colony Capital

$2.63 /

+0.28 (+11.94%)

, MOBL

MobileIron

$6.62 /

+1.07 (+19.28%)

, FLR

Fluor

$9.60 /

+0.24 (+2.56%)

, AG

First Majestic

$9.51 /

-0.745 (-7.26%)

Stocks finished out the…

ShowHide Related Items >><<
WMT Walmart
$137.25 /

+0.54 (+0.39%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

SNY Sanofi
$50.81 /

+0.04 (+0.08%)

ORCL Oracle
$59.80 /

+0.49 (+0.83%)

NVAX Novavax
$113.51 /

+11.03 (+10.76%)

MOBL MobileIron
$6.62 /

+1.07 (+19.28%)

GOOGL Alphabet Class A
$1,440.67 /

+19.2 (+1.35%)

GOOG Alphabet
$1,444.74 /

+18.02 (+1.26%)

FLR Fluor
$9.60 /

+0.24 (+2.56%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

COST Costco
$342.25 /

-4.75 (-1.37%)

CLNY Colony Capital
$2.63 /

+0.28 (+11.94%)

BA Boeing
$156.07 /

+10.08 (+6.90%)

AZN AstraZeneca
$55.53 /

+1.37 (+2.53%)

APO Apollo Global
$44.72 /

+1.865 (+4.35%)

AG First Majestic
$9.51 /

-0.745 (-7.26%)

AAPL Apple
$112.22 /

+4.02 (+3.72%)

COST Costco
$342.25 /

-4.75 (-1.37%)

09/25/20 MKM Partners
Costco price target raised to $325 from $320 at MKM Partners
09/25/20 RBC Capital
Costco price target raised to $412 from $400 at RBC Capital
09/25/20 BMO Capital
Costco price target raised to $385 from $340 at BMO Capital
09/25/20 Raymond James
Costco price target raised to $365 from $355 at Raymond James
WIMHY William Hill
$0.00 /

+ (+0.00%)

09/14/20 Jefferies
William Hill shares haven't priced in building U.S. momentum, says Jefferies
09/10/20 Berenberg
William Hill price target raised to 200 GBp from 150 GBp at Berenberg
09/09/20 Morgan Stanley
William Hill price target raised to 230 GBp from 200 GBp at Morgan Stanley
09/08/20 Barclays
William Hill price target raised to 240 GBp from 200 GBp at Barclays
CZR Caesars
$57.19 /

+4.4 (+8.33%)

09/25/20 JPMorgan
Caesars price target raised to $63 from $55 at JPMorgan
09/24/20 Truist
Truist raises price targets on select Gaming names
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
09/22/20 Roth Capital
Caesars value creation of $38/share through spinoff likely this year, says Roth
APO Apollo Global
$44.72 /

+1.865 (+4.35%)

07/01/20 Barclays
Apollo Global price target raised to $51 from $44 at Barclays
06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Goldman Sachs
Apollo Global downgraded to Buy from Conviction Buy at Goldman Sachs
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
NVAX Novavax
$113.51 /

+11.03 (+10.76%)

09/25/20 Raymond James
Endo deal could generate $50M-$75M in cash inflow, says Raymond James
09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
AZN AstraZeneca
$55.53 /

+1.37 (+2.53%)

09/23/20 Oddo BHF
AstraZeneca upgraded to Buy from Reduce at Oddo BHF
09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
SNY Sanofi
$50.81 /

+0.04 (+0.08%)

09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
AAPL Apple
$112.22 /

+4.02 (+3.72%)

09/25/20 Exane BNP Paribas
Exane double upgrades Qualcomm on share gains from Huawei ban
09/23/20 Jefferies
Facebook risk/reward 'remains compelling,' says Jefferies
09/22/20
UBS assumes Apple with Neutral from Buy amid 'maturing' iPhone growth
09/22/20 UBS
Apple assumed with Neutral from Buy at UBS
GOOG Alphabet
$1,444.74 /

+18.02 (+1.26%)

09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/18/20 Morgan Stanley
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
08/25/20 UBS
Alphabet price target raised to $1,970 from $1,600 at UBS
GOOGL Alphabet Class A
$1,440.67 /

+19.2 (+1.35%)

09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
ORCL Oracle
$59.80 /

+0.49 (+0.83%)

09/22/20 Morgan Stanley
Morgan Stanley says hard to tell if TikTok deal true 'thesis-changer' for Oracle
09/21/20
Fly Intel: Top five analyst upgrades
09/21/20 William Blair
TikTok deal 'major coup' for Oracle, says William Blair
09/21/20 RBC Capital
Oracle upgraded to Outperform from Sector Perform at RBC Capital
WMT Walmart
$137.25 /

+0.54 (+0.39%)

09/24/20 SVB Leerink
SVB Leerink bullish on Oak Street Health, initiates with an Outperform
09/23/20 BWS Financial
Arlo relationship with Walmart not fully realized, says BWS Financial
09/22/20 KeyBanc
Echelon Prime Bike not 'significant impediment' to Peloton growth, says KeyBanc
BA Boeing
$156.07 /

+10.08 (+6.90%)

09/24/20 Wolfe Research
Boeing upgraded to Peer Perform from Underperform at Wolfe Research
09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/20/20 Goldman Sachs
Boeing upgraded to Conviction Buy from Buy at Goldman Sachs
09/10/20 Susquehanna
Boeing 737 MAX making progress, but estimates lowered at Susquehanna
CLNY Colony Capital
$2.63 /

+0.28 (+11.94%)

06/04/20 B. Riley FBR
Colony Capital price target lowered to $4 from $5 at B. Riley FBR
03/11/20 B. Riley FBR
B. Riley FBR downgrades CNO Financial, Progressive to Neutral from Buy
MOBL MobileIron
$6.62 /

+1.07 (+19.28%)

09/25/20 Raymond James
MobileIron deal could make sense at $7.50-$9.00 per share, says Raymond James
07/30/20 Northland
MobileIron price target raised to $6 from $5 at Northland
05/06/20 Northland
MobileIron downgraded to Market Perform upon transfer at Northland
05/06/20 Northland
MobileIron downgraded to Market Perform from Outperform at Northland
FLR Fluor
$9.60 /

+0.24 (+2.56%)

04/27/20 Citi
Fluor downgraded to Neutral from Buy at Citi
04/27/20 UBS
Fluor downgraded to Neutral from Buy at UBS
02/19/20
Fly Intel: Top five analyst downgrades
02/19/20 DA Davidson
Fluor price target lowered to $15 from $22 at DA Davidson
AG First Majestic
$9.51 /

-0.745 (-7.26%)

09/11/20 National Bank
First Majestic price target raised to C$20 from C$19 at National Bank
08/10/20 BMO Capital
First Majestic price target raised to C$15 from C$12.50 at BMO Capital
07/24/20 TD Securities
First Majestic downgraded to Hold from Buy at TD Securities
05/21/20 National Bank
First Majestic price target raised to C$16 from C$12.50 at National Bank
WMT Walmart
$137.25 /

+0.54 (+0.39%)

SNY Sanofi
$50.81 /

+0.04 (+0.08%)

ORCL Oracle
$59.80 /

+0.49 (+0.83%)

NVAX Novavax
$113.51 /

+11.03 (+10.76%)

MOBL MobileIron
$6.62 /

+1.07 (+19.28%)

GOOG Alphabet
$1,444.74 /

+18.02 (+1.26%)

FLR Fluor
$9.60 /

+0.24 (+2.56%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

COST Costco
$342.25 /

-4.75 (-1.37%)

CLNY Colony Capital
$2.63 /

+0.28 (+11.94%)

BA Boeing
$156.07 /

+10.08 (+6.90%)

AZN AstraZeneca
$55.53 /

+1.37 (+2.53%)

APO Apollo Global
$44.72 /

+1.865 (+4.35%)

AG First Majestic
$9.51 /

-0.745 (-7.26%)

AAPL Apple
$112.22 /

+4.02 (+3.72%)

  • 26
    Nov
WIMHY William Hill
$0.00 /

+ (+0.00%)

SNY Sanofi
$50.81 /

+0.04 (+0.08%)

ORCL Oracle
$59.80 /

+0.49 (+0.83%)

NVAX Novavax
$113.51 /

+11.03 (+10.76%)

MOBL MobileIron
$6.62 /

+1.07 (+19.28%)

GOOG Alphabet
$1,444.74 /

+18.02 (+1.26%)

FLR Fluor
$9.60 /

+0.24 (+2.56%)

COST Costco
$342.25 /

-4.75 (-1.37%)

CLNY Colony Capital
$2.63 /

+0.28 (+11.94%)

BA Boeing
$156.07 /

+10.08 (+6.90%)

AZN AstraZeneca
$55.53 /

+1.37 (+2.53%)

APO Apollo Global
$44.72 /

+1.865 (+4.35%)

AAPL Apple
$112.22 /

+4.02 (+3.72%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

SNY Sanofi
$50.81 /

+0.04 (+0.08%)

ORCL Oracle
$59.80 /

+0.49 (+0.83%)

NVAX Novavax
$113.51 /

+11.03 (+10.76%)

MOBL MobileIron
$6.62 /

+1.07 (+19.28%)

GOOG Alphabet
$1,444.74 /

+18.02 (+1.26%)

FLR Fluor
$9.60 /

+0.24 (+2.56%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

COST Costco
$342.25 /

-4.75 (-1.37%)

BA Boeing
$156.07 /

+10.08 (+6.90%)

AZN AstraZeneca
$55.53 /

+1.37 (+2.53%)

APO Apollo Global
$44.72 /

+1.865 (+4.35%)

AAPL Apple
$112.22 /

+4.02 (+3.72%)

WMT Walmart
$137.25 /

+0.54 (+0.39%)

SNY Sanofi
$50.81 /

+0.04 (+0.08%)

ORCL Oracle
$59.80 /

+0.49 (+0.83%)

NVAX Novavax
$113.51 /

+11.03 (+10.76%)

GOOGL Alphabet Class A
$1,440.67 /

+19.2 (+1.35%)

FLR Fluor
$9.60 /

+0.24 (+2.56%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

COST Costco
$342.25 /

-4.75 (-1.37%)

BA Boeing
$156.07 /

+10.08 (+6.90%)

AZN AstraZeneca
$55.53 /

+1.37 (+2.53%)

APO Apollo Global
$44.72 /

+1.865 (+4.35%)

AG First Majestic
$9.51 /

-0.745 (-7.26%)

AAPL Apple
$112.22 /

+4.02 (+3.72%)

AAPL Apple
$112.22 /

+4.02 (+3.72%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:20
09/25/20
09/25
12:20
09/25/20
12:20
COST

Costco

$339.23 /

-7.77 (-2.24%)

, CZR

Caesars

$56.08 /

+3.29 (+6.23%)

, APO

Apollo Global

$43.87 /

+1.015 (+2.37%)

, WIMHY

William Hill

$0.00 /

+ (+0.00%)

, CLNY

Colony Capital

$2.56 /

+0.215 (+9.17%)

, MOBL

MobileIron

$6.57 /

+1.02 (+18.38%)

, NVAX

Novavax

$114.90 /

+12.42 (+12.12%)

, AZN

AstraZeneca

$54.40 /

+0.24 (+0.44%)

, FLR

Fluor

$8.92 /

-0.44 (-4.70%)

, AG

First Majestic

$9.56 /

-0.7 (-6.83%)

The major averages are…

ShowHide Related Items >><<
WIMHY William Hill
$0.00 /

+ (+0.00%)

NVAX Novavax
$114.90 /

+12.42 (+12.12%)

MOBL MobileIron
$6.57 /

+1.02 (+18.38%)

FLR Fluor
$8.92 /

-0.44 (-4.70%)

CZR Caesars
$56.08 /

+3.29 (+6.23%)

COST Costco
$339.23 /

-7.77 (-2.24%)

CLNY Colony Capital
$2.56 /

+0.215 (+9.17%)

AZN AstraZeneca
$54.40 /

+0.24 (+0.44%)

APO Apollo Global
$43.87 /

+1.015 (+2.37%)

AG First Majestic
$9.56 /

-0.7 (-6.83%)

COST Costco
$339.23 /

-7.77 (-2.24%)

09/25/20 MKM Partners
Costco price target raised to $325 from $320 at MKM Partners
09/25/20 RBC Capital
Costco price target raised to $412 from $400 at RBC Capital
09/25/20 BMO Capital
Costco price target raised to $385 from $340 at BMO Capital
09/25/20 Raymond James
Costco price target raised to $365 from $355 at Raymond James
CZR Caesars
$56.08 /

+3.29 (+6.23%)

09/25/20 JPMorgan
Caesars price target raised to $63 from $55 at JPMorgan
09/24/20 Truist
Truist raises price targets on select Gaming names
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
09/22/20 Roth Capital
Caesars value creation of $38/share through spinoff likely this year, says Roth
APO Apollo Global
$43.87 /

+1.015 (+2.37%)

07/01/20 Barclays
Apollo Global price target raised to $51 from $44 at Barclays
06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Goldman Sachs
Apollo Global downgraded to Buy from Conviction Buy at Goldman Sachs
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
WIMHY William Hill
$0.00 /

+ (+0.00%)

09/14/20 Jefferies
William Hill shares haven't priced in building U.S. momentum, says Jefferies
09/10/20 Berenberg
William Hill price target raised to 200 GBp from 150 GBp at Berenberg
09/09/20 Morgan Stanley
William Hill price target raised to 230 GBp from 200 GBp at Morgan Stanley
09/08/20 Barclays
William Hill price target raised to 240 GBp from 200 GBp at Barclays
CLNY Colony Capital
$2.56 /

+0.215 (+9.17%)

06/04/20 B. Riley FBR
Colony Capital price target lowered to $4 from $5 at B. Riley FBR
03/11/20 B. Riley FBR
B. Riley FBR downgrades CNO Financial, Progressive to Neutral from Buy
MOBL MobileIron
$6.57 /

+1.02 (+18.38%)

09/25/20 Raymond James
MobileIron deal could make sense at $7.50-$9.00 per share, says Raymond James
07/30/20 Northland
MobileIron price target raised to $6 from $5 at Northland
05/06/20 Northland
MobileIron downgraded to Market Perform upon transfer at Northland
05/06/20 Northland
MobileIron downgraded to Market Perform from Outperform at Northland
NVAX Novavax
$114.90 /

+12.42 (+12.12%)

09/25/20 Raymond James
Endo deal could generate $50M-$75M in cash inflow, says Raymond James
09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
AZN AstraZeneca
$54.40 /

+0.24 (+0.44%)

09/23/20 Oddo BHF
AstraZeneca upgraded to Buy from Reduce at Oddo BHF
09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
FLR Fluor
$8.92 /

-0.44 (-4.70%)

04/27/20 Citi
Fluor downgraded to Neutral from Buy at Citi
04/27/20 UBS
Fluor downgraded to Neutral from Buy at UBS
02/19/20
Fly Intel: Top five analyst downgrades
02/19/20 DA Davidson
Fluor price target lowered to $15 from $22 at DA Davidson
AG First Majestic
$9.56 /

-0.7 (-6.83%)

09/11/20 National Bank
First Majestic price target raised to C$20 from C$19 at National Bank
08/10/20 BMO Capital
First Majestic price target raised to C$15 from C$12.50 at BMO Capital
07/24/20 TD Securities
First Majestic downgraded to Hold from Buy at TD Securities
05/21/20 National Bank
First Majestic price target raised to C$16 from C$12.50 at National Bank
NVAX Novavax
$114.90 /

+12.42 (+12.12%)

MOBL MobileIron
$6.57 /

+1.02 (+18.38%)

FLR Fluor
$8.92 /

-0.44 (-4.70%)

CZR Caesars
$56.08 /

+3.29 (+6.23%)

COST Costco
$339.23 /

-7.77 (-2.24%)

CLNY Colony Capital
$2.56 /

+0.215 (+9.17%)

AZN AstraZeneca
$54.40 /

+0.24 (+0.44%)

APO Apollo Global
$43.87 /

+1.015 (+2.37%)

AG First Majestic
$9.56 /

-0.7 (-6.83%)

  • 26
    Nov
NVAX Novavax
$114.90 /

+12.42 (+12.12%)

MOBL MobileIron
$6.57 /

+1.02 (+18.38%)

FLR Fluor
$8.92 /

-0.44 (-4.70%)

CZR Caesars
$56.08 /

+3.29 (+6.23%)

COST Costco
$339.23 /

-7.77 (-2.24%)

CLNY Colony Capital
$2.56 /

+0.215 (+9.17%)

AZN AstraZeneca
$54.40 /

+0.24 (+0.44%)

APO Apollo Global
$43.87 /

+1.015 (+2.37%)

NVAX Novavax
$114.90 /

+12.42 (+12.12%)

MOBL MobileIron
$6.57 /

+1.02 (+18.38%)

FLR Fluor
$8.92 /

-0.44 (-4.70%)

CZR Caesars
$56.08 /

+3.29 (+6.23%)

COST Costco
$339.23 /

-7.77 (-2.24%)

AZN AstraZeneca
$54.40 /

+0.24 (+0.44%)

APO Apollo Global
$43.87 /

+1.015 (+2.37%)

NVAX Novavax
$114.90 /

+12.42 (+12.12%)

FLR Fluor
$8.92 /

-0.44 (-4.70%)

CZR Caesars
$56.08 /

+3.29 (+6.23%)

COST Costco
$339.23 /

-7.77 (-2.24%)

AZN AstraZeneca
$54.40 /

+0.24 (+0.44%)

APO Apollo Global
$43.87 /

+1.015 (+2.37%)

AG First Majestic
$9.56 /

-0.7 (-6.83%)

Recommendations
Endo deal could generate $50M-$75M in cash inflow, says Raymond James » 11:29
09/25/20
09/25
11:29
09/25/20
11:29
ENDP

Endo

$3.23 /

+0.205 (+6.78%)

, NVAX

Novavax

$114.08 /

+11.6 (+11.32%)

After Endo International…

After Endo International (ENDP) announced that its subsidiary, Par Sterile Products, has entered into a non-exclusive agreement with Novavax (NVAX) to provide fill-finish manufacturing services for the latter's COVID-19 vaccine candidate, Raymond James analyst Elliot Wilbur said Endo "might seem like the least obvious of potential manufacturing partners for a potential COVID-19 vaccine," but "it shouldn't be." The analyst, who noted that no indication was offered around economics of the deal or even what portion of the total number of produced doses Endo would ultimately provide services for, said his " best guess is that this arrangement would generate very low per dose numbers on the Endo end, perhaps even under $0.10 per dose." However, given the potential for a large number of initial doses, the deal could still generate $50M-$75M in cash inflow for Endo, according to Wilbur, who has a Market Perform rating on Endo shares.

ShowHide Related Items >><<
NVAX Novavax
$114.08 /

+11.6 (+11.32%)

ENDP Endo
$3.23 /

+0.205 (+6.78%)

ENDP Endo
$3.23 /

+0.205 (+6.78%)

07/27/20 Goldman Sachs
Endo initiated with a Sell at Goldman Sachs
06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
NVAX Novavax
$114.08 /

+11.6 (+11.32%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate
NVAX Novavax
$114.08 /

+11.6 (+11.32%)

ENDP Endo
$3.23 /

+0.205 (+6.78%)

NVAX Novavax
$114.08 /

+11.6 (+11.32%)

NVAX Novavax
$114.08 /

+11.6 (+11.32%)

ENDP Endo
$3.23 /

+0.205 (+6.78%)

NVAX Novavax
$114.08 /

+11.6 (+11.32%)

ENDP Endo
$3.23 /

+0.205 (+6.78%)

Options
Novavax call volume above normal and directionally bullish » 10:25
09/25/20
09/25
10:25
09/25/20
10:25
NVAX

Novavax

$112.00 /

+9.52 (+9.29%)

Bullish option flow…

Bullish option flow detected in Novavax with 14,271 calls trading, 4x expected, and implied vol increasing almost 4 points to 123.41%. 9/25 weekly 112 calls and 9/25 weekly 110 calls are the most active options, with total volume in those strikes near 1,800 contracts. The Put/Call Ratio is 0.34. Earnings are expected on November 5th.

ShowHide Related Items >><<
NVAX Novavax
$112.00 /

+9.52 (+9.29%)

NVAX Novavax
$112.00 /

+9.52 (+9.29%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate
NVAX Novavax
$112.00 /

+9.52 (+9.29%)

NVAX Novavax
$112.00 /

+9.52 (+9.29%)

NVAX Novavax
$112.00 /

+9.52 (+9.29%)

NVAX Novavax
$112.00 /

+9.52 (+9.29%)

Options
Early notable gainers among liquid option names on September 25th » 09:55
09/25/20
09/25
09:55
09/25/20
09:55
BBBY

Bed Bath & Beyond

$14.16 /

+0.22 (+1.58%)

, RCL

Royal Caribbean

$62.74 /

+2.75 (+4.58%)

, CCL

Carnival

$14.45 /

+0.71 (+5.17%)

, OI

O-I Glass

$9.69 /

+0.09 (+0.94%)

, HST

Host Hotels

$10.29 /

+0.095 (+0.93%)

Notable gainers among…

Notable gainers among liquid option names this morning include Carnival (CCL) $14.39 +0.66, Royal Caribbean (RCL) $62.69 +2.71, Bed Bath & Beyond (BBBY) $14.24 +0.30, Owens-Illinois (OI) $9.80 +0.20, and Host Hotels (HST) $10.39 +0.20.

ShowHide Related Items >><<
RCL Royal Caribbean
$62.74 /

+2.75 (+4.58%)

OI O-I Glass
$9.69 /

+0.09 (+0.94%)

HST Host Hotels
$10.29 /

+0.095 (+0.93%)

CCL Carnival
$14.45 /

+0.71 (+5.17%)

BBBY Bed Bath & Beyond
$14.16 /

+0.22 (+1.58%)

BBBY Bed Bath & Beyond
$14.16 /

+0.22 (+1.58%)

09/24/20
Fly Intel: Top five analyst upgrades
09/24/20 Baird
Baird upgrades Bed Bath & Beyond to Outperform on turnaround potential
09/24/20 Baird
Bed Bath & Beyond upgraded to Outperform from Neutral at Baird
09/10/20 Wedbush
Bed Bath & Beyond added to Best Ideas List, price raised to $18 at Wedbush
RCL Royal Caribbean
$62.74 /

+2.75 (+4.58%)

09/25/20 Barclays
Cruise stocks higher after Barclays upgrades three into 'inflection point'
09/25/20 Barclays
Royal Caribbean upgraded to Overweight from Equal Weight at Barclays
08/25/20 Argus
Argus widens Royal Caribbean expected earnings losses
08/12/20 Credit Suisse
Royal Caribbean price target raised to $75 from $67 at Credit Suisse
CCL Carnival
$14.45 /

+0.71 (+5.17%)

09/25/20 Barclays
Carnival upgraded to Overweight from Equal Weight at Barclays
07/29/20 Berenberg
Berenberg upgrades Carnival plc to Hold, keeps Carnival Corp. at Sell
07/29/20 Berenberg
Carnival plc upgraded to Hold from Sell at Berenberg
OI O-I Glass
$9.69 /

+0.09 (+0.94%)

08/06/20 Deutsche Bank
O-I Glass price target raised to $15 from $11 at Deutsche Bank
07/16/20 Baird
O-I Glass volume improved during June, says Baird
04/30/20 Barclays
O-I Glass price target lowered to $8 from $13 at Barclays
04/17/20 Wells Fargo
O-I Glass downgraded to Underweight from Equal Weight at Wells Fargo
HST Host Hotels
$10.29 /

+0.095 (+0.93%)

07/29/20 Morgan Stanley
Morgan Stanley upgrades Sunstone Hotel to Equal Weight after underperformance
07/29/20 Morgan Stanley
Morgan Stanley upgrades Host Hotels to Equal Weight following underperformance
07/29/20 Morgan Stanley
Host Hotels upgraded to Equal Weight from Underweight at Morgan Stanley
07/24/20 Truist
SunTrust cuts lodging REITs to Sell, Park Hotels double-downgraded from Buy
RCL Royal Caribbean
$62.74 /

+2.75 (+4.58%)

OI O-I Glass
$9.69 /

+0.09 (+0.94%)

HST Host Hotels
$10.29 /

+0.095 (+0.93%)

CCL Carnival
$14.45 /

+0.71 (+5.17%)

BBBY Bed Bath & Beyond
$14.16 /

+0.22 (+1.58%)

  • 02
    Apr
RCL Royal Caribbean
$62.74 /

+2.75 (+4.58%)

CCL Carnival
$14.45 /

+0.71 (+5.17%)

BBBY Bed Bath & Beyond
$14.16 /

+0.22 (+1.58%)

RCL Royal Caribbean
$62.74 /

+2.75 (+4.58%)

HST Host Hotels
$10.29 /

+0.095 (+0.93%)

CCL Carnival
$14.45 /

+0.71 (+5.17%)

BBBY Bed Bath & Beyond
$14.16 /

+0.22 (+1.58%)

RCL Royal Caribbean
$62.74 /

+2.75 (+4.58%)

OI O-I Glass
$9.69 /

+0.09 (+0.94%)

HST Host Hotels
$10.29 /

+0.095 (+0.93%)

CCL Carnival
$14.45 /

+0.71 (+5.17%)

BBBY Bed Bath & Beyond
$14.16 /

+0.22 (+1.58%)

Options
Unusually active option classes on open September 25th » 09:40
09/25/20
09/25
09:40
09/25/20
09:40
JE

Just Energy

$0.55 /

+ (+0.00%)

, BMY

Bristol-Myers

$58.24 /

+ (+0.00%)

, NCLH

Norwegian Cruise Line

$14.64 /

+0.01 (+0.07%)

, GS

Goldman Sachs

$195.12 /

+ (+0.00%)

, CCL

Carnival

$13.73 /

-0.01 (-0.07%)

, ZM

Zoom Video

$465.38 /

-0.12 (-0.03%)

, PENN

Penn National

$64.05 /

-0.01 (-0.02%)

, NVAX

Novavax

$102.48 /

+ (+0.00%)

, ROKU

Roku

$177.68 /

-0.07 (-0.04%)

Unusual total active…

Unusual total active option classes on open include: Just Energy (JE), Bristol Myers Squibb (BMY), Norwegian Cruise Line (NCLH), Direxion Daily S&P Bear (SPXS), Goldman Sachs (GS), Carnival (CCL), Zoom Video Communications (ZM), Penn National (PENN), Novavax (NVAX), and Roku (ROKU).

ShowHide Related Items >><<
ZM Zoom Video
$465.38 /

-0.12 (-0.03%)

ROKU Roku
$177.68 /

-0.07 (-0.04%)

PENN Penn National
$64.05 /

-0.01 (-0.02%)

NVAX Novavax
$102.48 /

+ (+0.00%)

NCLH Norwegian Cruise Line
$14.64 /

+0.01 (+0.07%)

JE Just Energy
$0.55 /

+ (+0.00%)

GS Goldman Sachs
$195.12 /

+ (+0.00%)

CCL Carnival
$13.73 /

-0.01 (-0.07%)

BMY Bristol-Myers
$58.24 /

+ (+0.00%)

JE Just Energy
$0.55 /

+ (+0.00%)

07/29/20 RBC Capital
Just Energy downgraded to Underperform from Sector Perform at RBC Capital
07/20/20 Morgan Stanley
Just Energy price target lowered to 80 GBp from 85 GBp at Morgan Stanley
07/10/20 CIBC
Just Energy price target lowered to C$0.50 from C$0.75 at CIBC
07/10/20 RBC Capital
Just Energy price target lowered to C$0.30 from C$1 at RBC Capital
BMY Bristol-Myers
$58.24 /

+ (+0.00%)

09/22/20 Oppenheimer
Bluebird Bio review timeline consistent with expectations, says Oppenheimer
08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
NCLH Norwegian Cruise Line
$14.64 /

+0.01 (+0.07%)

09/25/20 Barclays
Cruise stocks higher after Barclays upgrades three into 'inflection point'
09/25/20 Barclays
Norwegian Cruise Line upgraded to Overweight from Equal Weight at Barclays
07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 Truist
Cruise Line operators downgraded at SunTrust on delayed starting dates
GS Goldman Sachs
$195.12 /

+ (+0.00%)

09/23/20 UBS
Goldman Sachs upgraded to Buy from Neutral at UBS
08/06/20 Piper Sandler
Now is the time to buy Goldman Sachs, says Piper Sandler
07/20/20 Berenberg
Goldman Sachs price target raised to $200 from $160 at Berenberg
07/16/20 DA Davidson
Goldman Sachs price target raised to $238 from $215 at DA Davidson
CCL Carnival
$13.73 /

-0.01 (-0.07%)

09/25/20 Barclays
Carnival upgraded to Overweight from Equal Weight at Barclays
07/29/20 Berenberg
Berenberg upgrades Carnival plc to Hold, keeps Carnival Corp. at Sell
07/29/20 Berenberg
Carnival plc upgraded to Hold from Sell at Berenberg
ZM Zoom Video
$465.38 /

-0.12 (-0.03%)

09/21/20
Snowflake initiated with a Sell at Summit Insights
09/14/20 Baird
Zoom Video still in early innings of market penetration, says Baird
09/03/20 Needham
Crowdstrike price target raised to $170 from $120 at Needham
09/03/20 Stifel
Crowdstrike price target raised to $145 from $125 at Stifel
PENN Penn National
$64.05 /

-0.01 (-0.02%)

09/24/20
Fly Intel: Top five analyst downgrades
09/24/20 Truist
Truist raises price targets on select Gaming names
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
NVAX Novavax
$102.48 /

+ (+0.00%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate
ROKU Roku
$177.68 /

-0.07 (-0.04%)

09/18/20 Rosenblatt
Rosenblatt would be buyer on any Roku weakness amid latest Comcast 'tiff'
09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Roku initiated with an Overweight at KeyBanc
09/14/20 KeyBanc
Roku initiated with an Overweight at KeyBanc
ZM Zoom Video
$465.38 /

-0.12 (-0.03%)

ROKU Roku
$177.68 /

-0.07 (-0.04%)

PENN Penn National
$64.05 /

-0.01 (-0.02%)

NVAX Novavax
$102.48 /

+ (+0.00%)

NCLH Norwegian Cruise Line
$14.64 /

+0.01 (+0.07%)

JE Just Energy
$0.55 /

+ (+0.00%)

GS Goldman Sachs
$195.12 /

+ (+0.00%)

CCL Carnival
$13.73 /

-0.01 (-0.07%)

BMY Bristol-Myers
$58.24 /

+ (+0.00%)

  • 25
    Sep
  • 17
    Jul
  • 12
    May
  • 06
    May
  • 02
    Apr
  • 17
    Mar
ZM Zoom Video
$465.38 /

-0.12 (-0.03%)

ROKU Roku
$177.68 /

-0.07 (-0.04%)

PENN Penn National
$64.05 /

-0.01 (-0.02%)

NVAX Novavax
$102.48 /

+ (+0.00%)

NCLH Norwegian Cruise Line
$14.64 /

+0.01 (+0.07%)

GS Goldman Sachs
$195.12 /

+ (+0.00%)

CCL Carnival
$13.73 /

-0.01 (-0.07%)

BMY Bristol-Myers
$58.24 /

+ (+0.00%)

ZM Zoom Video
$465.38 /

-0.12 (-0.03%)

ROKU Roku
$177.68 /

-0.07 (-0.04%)

PENN Penn National
$64.05 /

-0.01 (-0.02%)

NVAX Novavax
$102.48 /

+ (+0.00%)

NCLH Norwegian Cruise Line
$14.64 /

+0.01 (+0.07%)

GS Goldman Sachs
$195.12 /

+ (+0.00%)

CCL Carnival
$13.73 /

-0.01 (-0.07%)

BMY Bristol-Myers
$58.24 /

+ (+0.00%)

ZM Zoom Video
$465.38 /

-0.12 (-0.03%)

ROKU Roku
$177.68 /

-0.07 (-0.04%)

PENN Penn National
$64.05 /

-0.01 (-0.02%)

NVAX Novavax
$102.48 /

+ (+0.00%)

NCLH Norwegian Cruise Line
$14.64 /

+0.01 (+0.07%)

GS Goldman Sachs
$195.12 /

+ (+0.00%)

CCL Carnival
$13.73 /

-0.01 (-0.07%)

BMY Bristol-Myers
$58.24 /

+ (+0.00%)

On The Fly
Fly Intel: Pre-market Movers » 09:08
09/25/20
09/25
09:08
09/25/20
09:08
APO

Apollo Global

$42.86 /

-1.125 (-2.56%)

, WIMHY

William Hill

$0.00 /

+ (+0.00%)

, NVAX

Novavax

$102.48 /

+0.92 (+0.91%)

, DKNG

DraftKings

$50.58 /

+0.48 (+0.96%)

, CLNY

Colony Capital

$2.34 /

-0.03 (-1.27%)

, OUT

Outfront Media

$14.00 /

-0.16 (-1.13%)

, ALT

Altimmune

$12.03 /

-0.5 (-3.99%)

, COST

Costco

$347.25 /

+2.67 (+0.77%)

, FLR

Fluor

$9.35 /

+0.865 (+10.19%)

, NETE

Net Element

$8.60 /

+2.16 (+33.54%)

, ENDP

Endo

$3.03 /

-0.035 (-1.14%)

Check out this morning's…

ShowHide Related Items >><<
WIMHY William Hill
$0.00 /

+ (+0.00%)

OUT Outfront Media
$14.00 /

-0.16 (-1.13%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

NETE Net Element
$8.60 /

+2.16 (+33.54%)

FLR Fluor
$9.35 /

+0.865 (+10.19%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

COST Costco
$347.25 /

+2.67 (+0.77%)

CLNY Colony Capital
$2.34 /

-0.03 (-1.27%)

APO Apollo Global
$42.86 /

-1.125 (-2.56%)

ALT Altimmune
$12.03 /

-0.5 (-3.99%)

APO Apollo Global
$42.86 /

-1.125 (-2.56%)

07/01/20 Barclays
Apollo Global price target raised to $51 from $44 at Barclays
06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Goldman Sachs
Apollo Global downgraded to Buy from Conviction Buy at Goldman Sachs
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
WIMHY William Hill
$0.00 /

+ (+0.00%)

09/14/20 Jefferies
William Hill shares haven't priced in building U.S. momentum, says Jefferies
09/10/20 Berenberg
William Hill price target raised to 200 GBp from 150 GBp at Berenberg
09/09/20 Morgan Stanley
William Hill price target raised to 230 GBp from 200 GBp at Morgan Stanley
09/08/20 Barclays
William Hill price target raised to 240 GBp from 200 GBp at Barclays
NVAX Novavax
$102.48 /

+0.92 (+0.91%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate
DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

09/25/20 Argus
DraftKings initiated with a Buy at Argus
09/25/20 Argus
DraftKings initiated with a Buy at Argus
09/24/20
Fly Intel: Top five analyst initiations
09/24/20 Macquarie
DraftKings initiated with an Outperform at Macquarie
CLNY Colony Capital
$2.34 /

-0.03 (-1.27%)

06/04/20 B. Riley FBR
Colony Capital price target lowered to $4 from $5 at B. Riley FBR
03/11/20 B. Riley FBR
B. Riley FBR downgrades CNO Financial, Progressive to Neutral from Buy
OUT Outfront Media
$14.00 /

-0.16 (-1.13%)

09/25/20 Citi
Outfront Media upgraded to Buy from Neutral at Citi
06/24/20 Citi
Clear Channel Outdoor upgraded to Buy from Neutral at Citi
04/22/20 Imperial Capital
Outfront Media price target lowered to $22 from $24 at Imperial Capital
04/20/20 Morgan Stanley
Morgan Stanley downgrades Outfront Media, slashes price target to $13
ALT Altimmune
$12.03 /

-0.5 (-3.99%)

09/25/20 B. Riley FBR
Altimmune initiated with a Buy at B. Riley FBR
09/22/20 Piper Sandler
Altimmune nearing two 'key stock-moving events,' says Piper Sandler
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
08/25/20 Piper Sandler
Altimmune a 'stand out' from other COVID vaccine makers, says Piper Sandler
COST Costco
$347.25 /

+2.67 (+0.77%)

09/25/20 BMO Capital
Costco price target raised to $385 from $340 at BMO Capital
09/25/20 Raymond James
Costco price target raised to $365 from $355 at Raymond James
09/25/20 Morgan Stanley
Costco price target raised to $360 from $330 at Morgan Stanley
09/25/20 Baird
Costco chances of special dividend rising, says Baird
FLR Fluor
$9.35 /

+0.865 (+10.19%)

04/27/20 Citi
Fluor downgraded to Neutral from Buy at Citi
04/27/20 UBS
Fluor downgraded to Neutral from Buy at UBS
02/19/20
Fly Intel: Top five analyst downgrades
02/19/20 DA Davidson
Fluor price target lowered to $15 from $22 at DA Davidson
NETE Net Element
$8.60 /

+2.16 (+33.54%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

07/27/20 Goldman Sachs
Endo initiated with a Sell at Goldman Sachs
06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
OUT Outfront Media
$14.00 /

-0.16 (-1.13%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

FLR Fluor
$9.35 /

+0.865 (+10.19%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

COST Costco
$347.25 /

+2.67 (+0.77%)

CLNY Colony Capital
$2.34 /

-0.03 (-1.27%)

APO Apollo Global
$42.86 /

-1.125 (-2.56%)

ALT Altimmune
$12.03 /

-0.5 (-3.99%)

  • 14
    Jul
  • 19
    Jun
  • 26
    Nov
WIMHY William Hill
$0.00 /

+ (+0.00%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

FLR Fluor
$9.35 /

+0.865 (+10.19%)

DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

COST Costco
$347.25 /

+2.67 (+0.77%)

CLNY Colony Capital
$2.34 /

-0.03 (-1.27%)

APO Apollo Global
$42.86 /

-1.125 (-2.56%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

FLR Fluor
$9.35 /

+0.865 (+10.19%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

COST Costco
$347.25 /

+2.67 (+0.77%)

APO Apollo Global
$42.86 /

-1.125 (-2.56%)

ALT Altimmune
$12.03 /

-0.5 (-3.99%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

FLR Fluor
$9.35 /

+0.865 (+10.19%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

COST Costco
$347.25 /

+2.67 (+0.77%)

APO Apollo Global
$42.86 /

-1.125 (-2.56%)

ALT Altimmune
$12.03 /

-0.5 (-3.99%)

Hot Stocks
Novavax up 6% to $109.23 after agreement with Endo for NVX-CoV2373 » 07:17
09/25/20
09/25
07:17
09/25/20
07:17
NVAX

Novavax

$102.48 /

+0.92 (+0.91%)

, ENDP

Endo

$3.03 /

-0.035 (-1.14%)

Endo is up over 9% to…

Endo is up over 9% to $3.31 on the news.

ShowHide Related Items >><<
NVAX Novavax
$102.48 /

+0.92 (+0.91%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate
ENDP Endo
$3.03 /

-0.035 (-1.14%)

07/27/20 Goldman Sachs
Endo initiated with a Sell at Goldman Sachs
06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
NVAX Novavax
$102.48 /

+0.92 (+0.91%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

Hot Stocks
Endo subsidiary enters non-exclusive agreement with Novavax for NVX-CoV2373 » 07:02
09/25/20
09/25
07:02
09/25/20
07:02
ENDP

Endo

$3.03 /

-0.035 (-1.14%)

, NVAX

Novavax

$102.48 /

+0.92 (+0.91%)

Endo International (ENDP)…

Endo International (ENDP) announced that its subsidiary, Par Sterile Products, has entered into a non-exclusive agreement with Novavax (NVAX) to provide fill-finish manufacturing services at its plant in Rochester, Michigan for NVX-CoV2373, Novavax' COVID-19 vaccine candidate. Under the terms of the agreement, Par Sterile's Rochester facility has begun production of NVX-CoV2373 final drug product, with initial batches to be used in Novavax' pivotal Phase 3 clinical trial in the United States. Par Sterile will also fill-finish NVX-CoV2373 vaccine intended for commercial distribution in the United States. Financial and other terms of the agreement were not disclosed. NVX-CoV2373 is currently in multiple Phase 2 clinical trials. A Phase 2 clinical trial to evaluate the safety and immunogenicity of NVX-CoV2373 began in August 2020 in the United States and Australia building on positive Phase 1 results and expanding to include older adults. A Phase 2b clinical trial to assess efficacy began in South Africa in August 2020. Interim data for these trials is expected before the end of 2020.

ShowHide Related Items >><<
NVAX Novavax
$102.48 /

+0.92 (+0.91%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

07/27/20 Goldman Sachs
Endo initiated with a Sell at Goldman Sachs
06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
NVAX Novavax
$102.48 /

+0.92 (+0.91%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate
NVAX Novavax
$102.48 /

+0.92 (+0.91%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

ENDP Endo
$3.03 /

-0.035 (-1.14%)

Recommendations
CymaBay beating Genfit in primary biliary cholangitis race, says Piper Sandler » 05:08
09/25/20
09/25
05:08
09/25/20
05:08
CBAY

CymaBay

$6.35 /

+0.125 (+2.01%)

, GNFT

Genfit

$3.67 /

-0.28 (-7.09%)

Piper Sandler analyst…

Piper Sandler analyst Yasmeen Rahimi says that with Genfit's (GNFT) announcement of the first patient visit in its Phase 3 trial ahead of CymaBay's (CBAY) upcoming Phase 3 study of seladelpar, she believes seladelpar's "robust" biomarker response and improvement in pruritus will put the drug on top of elafibranor in the primary biliary cholangitis race. The analyst sees "several puzzling components" in Genfit's Phase 3 study and keeps an Overweight rating on CymaBay with a $12 price target.

ShowHide Related Items >><<
GNFT Genfit
$3.67 /

-0.28 (-7.09%)

CBAY CymaBay
$6.35 /

+0.125 (+2.01%)

CBAY CymaBay
$6.35 /

+0.125 (+2.01%)

09/09/20 B. Riley FBR
CymaBay price target raised to $13 from $9 at B. Riley FBR
08/27/20 Piper Sandler
Piper Sandler 'astonished' by seladelpar's long-term benefits
08/25/20 Citi
CymaBay price target raised to $9 from $7 at Citi
08/04/20 H.C. Wainwright
CymaBay price target raised to $13 from $9 at H.C. Wainwright
GNFT Genfit
$3.67 /

-0.28 (-7.09%)

08/05/20 H.C. Wainwright
Lancet publication 'strong validation' Genfit's NIS4, says H.C. Wainwright
07/23/20 H.C. Wainwright
Genfit price target lowered to $8 from $11 at H.C. Wainwright
07/23/20
Fly Intel: Top five analyst upgrades
07/23/20 Stifel
Genfit upgraded to Buy from Hold at Stifel
CBAY CymaBay
$6.35 /

+0.125 (+2.01%)

GNFT Genfit
$3.67 /

-0.28 (-7.09%)

CBAY CymaBay
$6.35 /

+0.125 (+2.01%)

CBAY CymaBay
$6.35 /

+0.125 (+2.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.